PMID- 33045807
OWN - NLM
STAT- MEDLINE
DCOM- 20210624
LR  - 20210701
IS  - 2005-6648 (Electronic)
IS  - 1226-3303 (Print)
IS  - 1226-3303 (Linking)
VI  - 36
IP  - 3
DP  - 2021 May
TI  - Recent advances in the diagnosis and management of interstitial pneumonia with 
      autoimmune features: the perspective of rheumatologists.
PG  - 515-526
LID - 10.3904/kjim.2020.443 [doi]
AB  - Interstitial pneumonia with autoimmune feature (IPAF) is a recently established 
      disease entity that is comprised of interstitial lung diseases with evidence of 
      autoimmune features but that does not fulfill the criteria for definite 
      autoimmune rheumatic diseases. The classification criteria for IPAF were defined 
      by the European Respiratory Society and American Thoracic Society in 2015. 
      However, further studies to establish IPAF subgroups and treatment modalities for 
      each subgroup are still needed. In this review, we discuss recent advances 
      regarding IPAF and raise critical points for the diagnosis and management of 
      patients with IPAF from the perspective of rheumatologists.
FAU - Min, Hong Ki
AU  - Min HK
AD  - Division of Rheumatology, Department of Internal Medicine, Konkuk University 
      Medical Center, Seoul, Korea.
FAU - Kim, Se-Hee
AU  - Kim SH
AD  - Division of Rheumatology, Department of Internal Medicine, Konkuk University 
      Medical Center, Seoul, Korea.
FAU - Lee, Sang-Heon
AU  - Lee SH
AD  - Division of Rheumatology, Department of Internal Medicine, Research Institute of 
      Medical Science, Konkuk University School of Medicine, Seoul, Korea.
FAU - Kim, Hae-Rim
AU  - Kim HR
AD  - Division of Rheumatology, Department of Internal Medicine, Research Institute of 
      Medical Science, Konkuk University School of Medicine, Seoul, Korea.
LA  - eng
GR  - 2018R1D1A1A02050982/National Research Foundation of Korea/
GR  - Ministry of Education, Science and Technology/
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
DEP - 20210208
PL  - Korea (South)
TA  - Korean J Intern Med
JT  - The Korean journal of internal medicine
JID - 8712418
SB  - IM
MH  - *Autoimmune Diseases/diagnosis/therapy
MH  - Humans
MH  - *Lung Diseases, Interstitial/diagnosis/therapy
MH  - *Rheumatic Diseases
MH  - Rheumatologists
PMC - PMC8137388
OTO - NOTNLM
OT  - Autoimmune diseases
OT  - Lung diseases, interstitial
OT  - Prognosis
OT  - Rheumatology
OT  - Therapy
COIS- Conflict of interest No potential conflict of interest relevant to this article 
      was reported.
EDAT- 2020/10/14 06:00
MHDA- 2021/06/25 06:00
PMCR- 2021/05/01
CRDT- 2020/10/13 02:56
PHST- 2020/08/21 00:00 [received]
PHST- 2020/10/07 00:00 [accepted]
PHST- 2020/10/14 06:00 [pubmed]
PHST- 2021/06/25 06:00 [medline]
PHST- 2020/10/13 02:56 [entrez]
PHST- 2021/05/01 00:00 [pmc-release]
AID - kjim.2020.443 [pii]
AID - kjim-2020-443 [pii]
AID - 10.3904/kjim.2020.443 [doi]
PST - ppublish
SO  - Korean J Intern Med. 2021 May;36(3):515-526. doi: 10.3904/kjim.2020.443. Epub 
      2021 Feb 8.